Top drugs in 2014

19 Apr

A recent reuters article took a look at expected pharma sales trend in 2014. Avastin by Roche is expected to lead the pack, closely followed by two anti-arthritic drugs by Abbott and Pfizer.
Consensus sales forecasts for world’s top 10 drugs in 2014:
1. Avastin (cancer) Roche $8.9 bln
2. Humira (arthritis) Abbott $8.5 bln
3. Enbrel (arthritis) Pfizer $8.0 bln
4. Crestor (cholesterol) AstraZeneca  $7.7 bln
5. Remicade (arthritis) Merck, J&J $7.6 bln
6. Rituxan (cancer) Roche $7.4 bln
7. Lantus (diabetes) Sanofi-Aventis $7.1 bln
8. Advair (asthma/COPD) GlaxoSmithKline  $6.8 bln
9. Herceptin (cancer) Roche $6.4 bln
10.NovoLog (diabetes) Novo Nordisk  $5.7 bln
As expected, most sales shall come from drugs against chronic and life style disorders.
Leave a comment

Posted by on April 19, 2010 in Uncategorized


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: